Methyclothiazide - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for methyclothiazide and what is the scope of patent protection?

Methyclothiazide is the generic ingredient in five branded drugs marketed by Medpointe Pharm Hlc, Abbvie, Chartwell Rx, Ivax Pharms, Mylan, Norvium Bioscience, Par Pharm, Usl Pharma, Watson Labs, and Abbott, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for methyclothiazide.

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Par Pharm	METHYCLOTHIAZIDE	methyclothiazide	TABLET;ORAL	089135-001	Feb 12, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Norvium Bioscience	METHYCLOTHIAZIDE	methyclothiazide	TABLET;ORAL	087672-001	Aug 17, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ivax Pharms	METHYCLOTHIAZIDE	methyclothiazide	TABLET;ORAL	087913-001	Jun 3, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mylan	METHYCLOTHIAZIDE	methyclothiazide	TABLET;ORAL	087671-001	Aug 17, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbvie	ENDURON	methyclothiazide	TABLET;ORAL	012524-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

US Patents:	0
Tradenames:	5
Applicants:	10
NDAs:	17
Drug Master File Entries:	2
Raw Ingredient (Bulk) Api Vendors:	68
Patent Applications:	6,765
DailyMed Link:	methyclothiazide at DailyMed